There is also a convergence of technology and loca
Post# of 22456
Posted on 30 Nov 2021 / 0 Comment / admin
Invest in TestMeTech
Singapore based Biotechnology Company TestMeTech to raise seed capital. Sources suggest TestMeTech valuation may reach a range of USD$600 million to USD$1.3B million once its Philippine Facility reaches full production.
A TestMeTech Spokesman said “Our proprietary Quantum Dot Technology means Sars-Cov2 and its more potent variants (example Delta and Omicron) can be tested using one test kit. There’s an insatiable interest from governments and distributors for our 3 in 1 test, especially as it’s a mouth swab rather than an invasive PCR”
What does TestMeTech do?
TestMeTech is a Nano-Biotech company that manufactures, and commercializes next-generation digital diagnostic products for medical professionals and consumers in the Asia Pacific regions. Its focus is on the accurate diagnosis of common infectious diseases using test kits are prescription-free, commercial use or DIY self-testing.
When the COVID pandemic expires, earnings are expected to grow because TestMeTech can also accurately tests other viruses such as HIV, Dengue and health challenges associated with livestock such as Avian Bird Flu and Asian Swine Flu.